Current Sexual Health Reports

, Volume 2, Issue 2, pp 51–53 | Cite as

Curing erectile dysfunction: Con

  • Dana A. Ohl
  • Jens Sønksen
Point/Counterpoint
  • 21 Downloads

Abstract

Several reports have suggested that erectile dysfunction can be cured through a variety of interventions. At best, some of the results are intriguing and suggest that further study in this area is warranted. Unfortunately, these studies have a multitude of methodologic problems and are not convincing in their conclusions. At the present time, although the concept of curing erectile dysfunction is appealing, we have fallen well short of achieving that goal.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54–61.PubMedGoogle Scholar
  2. 2.
    Braun MH, Sommer F, Haupt G, et al.: Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the Cologne Male Survey. Eur Urol 2003, 44:588–594.CrossRefPubMedGoogle Scholar
  3. 3.
    Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281:537–544.CrossRefPubMedGoogle Scholar
  4. 4.
    Tan HL: Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics 2000, 17:77–107.CrossRefPubMedGoogle Scholar
  5. 5.
    Montorsi F, Guazzoni G, Strambi LF, et al.: Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997, 158:1408–1410.CrossRefPubMedGoogle Scholar
  6. 6.
    Padma-Nathan H, McCullough AR, Giuliano F, et al.: Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003, 168(Suppl 4):375–376.Google Scholar
  7. 7.
    Claes H, Baert L: Pelvic floor exercise versus surgery in the treatment of impotence. Br J Urol 1993, 71:52–57.CrossRefPubMedGoogle Scholar
  8. 8.
    Dorey G: Conservative treatment of erectile dysfunction. 3: literature review. Br J Nurs 2000, 9:859–863.PubMedGoogle Scholar
  9. 9.
    Sommer F, Raible A, Bondarenko B, et al.: A conservative treatment option of curing venous leakage in impotent men. Eur Urol Suppl 2002, 1:153.CrossRefGoogle Scholar
  10. 10.
    Lewis RW: Venous surgery for impotence. Urol Clin North Am 1988, 15:115–121.PubMedGoogle Scholar
  11. 11.
    Imagawa A, Kawanishi Y, Tamura M: Intracavernous injection therapy in recovery of spontaneous erection (not for selfinjection)-its mechanism and indications. Hinyokika Kiyo 1989, 35:1145–1148.PubMedGoogle Scholar
  12. 12.
    Beretta G, Marzotto M, Zanollo A: Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections. Acta Eur Fertil 1991, 22:221–223.PubMedGoogle Scholar
  13. 13.
    Thiounn N, Flam T, Zerbib M, Debre B: [Does prostaglandin El (PGE1) help restoration of spontaneous erections?] [French]. J Urol 1993, 99:136–138.Google Scholar
  14. 14.
    Marshall GA, Breza J, Lue TF: Improved hemodynamic response after long-term intracavernous injection for impotence. Urology 43:844–848.Google Scholar
  15. 15.
    Brock G, Tu LM, Linet OI: Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001, 57:536–541.CrossRefPubMedGoogle Scholar
  16. 16.
    Sharlip ID: Does natural erectile function improve following intracavernous injections of vasoactive drugs? Int J Impot Res 1997, 9:193–196.CrossRefPubMedGoogle Scholar
  17. 17.
    Sommer F, Engelmann UH: What are the long term effects on erectile function of taking sildenafil on a daily basis [abstract]? J Urol 2004, 171(Suppl 4):239.Google Scholar
  18. 18.
    Guay AT, Perez JB, Jacobson J, Newton RA: Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001, 22:793–797.PubMedGoogle Scholar
  19. 19.
    Saltzman EA, Guay AT, Jacobson J: Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004, 172:255–258.CrossRefPubMedGoogle Scholar
  20. 20.
    Esposito K, Giugliano F, Di Palo C, et al.: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004, 291:2978–2984.CrossRefPubMedGoogle Scholar
  21. 21.
    Montorsi P, Ravagnani PM, Galli S, et al.: Common grounds for erectile dysfunction and coronary artery disease. Curr Opin Urol 2004, 14:361–365.CrossRefPubMedGoogle Scholar
  22. 22.
    Airey M, Bennett C, Nicolucci A, Williams R: Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy. Cochran Database Syst Rev 2000, 2:CD002182.Google Scholar
  23. 23.
    Nissen SE, Tuzcu EM, Schoenhagen P, et al.: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005, 352:29–38.CrossRefPubMedGoogle Scholar
  24. 24.
    Bivalacqua TJ, Usta MF, Champion HC, et al.: Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Uro 2003, 169:1911–1917.CrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Dana A. Ohl
    • 1
  • Jens Sønksen
  1. 1.Department of Urology, Division of Andrology and MicrosurgeryUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations